Literature DB >> 8865004

Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment.

R S Scheibel1, C A Meyers, V A Levin.   

Abstract

This study examined the relationship between cognitive function, tumor malignancy, adjunctive therapy, and lesion lateralization following surgery for intracerebral glioma. Neuropsychological test battery results showed no difference between patients with highly malignant gliomas and those with less malignant gliomas, but differences were found for tumor lateralization and type of therapy. Scores on a test of graphomotor speed were lowest for patients who had received radiation or a combination of radiation and chemotherapy, regardless of lesion location. Other test results did not differ according to type of prior treatment but were related instead to tumor lateralization. Left hemisphere lesions were associated with lower scores on verbal tests, while right hemisphere lesions were related to lower scores on a test of facial recognition. These findings suggest that neuropsychological tests may be useful for distinguishing between the diffuse side effects of brain tumor therapy and the focal effects of tumors and surgery on brain functions. In addition, it appears that any differences in cognitive function due to tumor malignancy are eliminated or reduced following surgical intervention.

Entities:  

Mesh:

Year:  1996        PMID: 8865004     DOI: 10.1007/bf00177444

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  18 in total

1.  Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men.

Authors:  E N Miller; P Satz; B Visscher
Journal:  Neurology       Date:  1991-10       Impact factor: 9.910

2.  THE MENTAL SYMPTOMS ASSOCIATED WITH 58 CASES OF CEREBRAL TUMOUR.

Authors:  L Minski
Journal:  J Neurol Psychopathol       Date:  1933-04

3.  Motor deficits after left or right hemisphere damage due to stroke or tumor.

Authors:  K Y Haaland; H D Delaney
Journal:  Neuropsychologia       Date:  1981       Impact factor: 3.139

4.  Simultaneous tests of many hypotheses in exploratory research.

Authors:  W M Grove; N C Andreasen
Journal:  J Nerv Ment Dis       Date:  1982-01       Impact factor: 2.254

5.  Psychologic changes associated with aging and with cerebral damage.

Authors:  R M Reitan
Journal:  Mayo Clin Proc       Date:  1967-10       Impact factor: 7.616

6.  Early detection and diagnosis of neurobehavioral disorders associated with cancer and its treatment.

Authors:  C A Meyers; R S Scheibel
Journal:  Oncology (Williston Park)       Date:  1990-07       Impact factor: 2.990

7.  Wisconsin Card Sorting Test performance as a measure of frontal lobe damage.

Authors:  S W Anderson; H Damasio; R D Jones; D Tranel
Journal:  J Clin Exp Neuropsychol       Date:  1991-11       Impact factor: 2.475

8.  Neuropsychological impairments associated with lesions caused by tumor or stroke.

Authors:  S W Anderson; H Damasio; D Tranel
Journal:  Arch Neurol       Date:  1990-04

9.  Prospective intellectual testing in children with brain tumors.

Authors:  P K Duffner; M E Cohen; M S Parker
Journal:  Ann Neurol       Date:  1988-06       Impact factor: 10.422

10.  Neuropsychological correlates of rapidly vs. slowly growing intrinsic cerebral neoplasms.

Authors:  J Hom; R M Reitan
Journal:  J Clin Neuropsychol       Date:  1984-08
View more
  45 in total

1.  Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood.

Authors:  Albert Attia; Stephen R Rapp; L Doug Case; Ralph D'Agostino; Glenn Lesser; Michelle Naughton; Kevin McMullen; Robin Rosdhal; Edward G Shaw
Journal:  J Neurooncol       Date:  2012-06-15       Impact factor: 4.130

2.  Neurocognitive Changes Associated With Surgical Resection of Left and Right Temporal Lobe Glioma.

Authors:  Kyle R Noll; Jeffrey S Weinberg; Mateo Ziu; Ronald J Benveniste; Dima Suki; Jeffrey S Wefel
Journal:  Neurosurgery       Date:  2015-11       Impact factor: 4.654

3.  Effect of massage therapy on stress levels and quality of life in brain tumor patients--observations from a pilot study.

Authors:  Stephen Thomas Keir
Journal:  Support Care Cancer       Date:  2010-11-03       Impact factor: 3.603

Review 4.  Emerging mechanistic underpinnings and therapeutic targets for chemotherapy-related cognitive impairment.

Authors:  Erin M Gibson; Michelle Monje
Journal:  Curr Opin Oncol       Date:  2019-11       Impact factor: 3.645

Review 5.  Neurocognitive functioning and genetic variation in patients with primary brain tumours.

Authors:  Jeffrey S Wefel; Kyle R Noll; Michael E Scheurer
Journal:  Lancet Oncol       Date:  2016-03-02       Impact factor: 41.316

Review 6.  Investigation of cognitive impairments in people with brain tumors.

Authors:  Anna Rita Giovagnoli
Journal:  J Neurooncol       Date:  2012-03-06       Impact factor: 4.130

7.  Acute effects of surgery on emotion and personality of brain tumor patients: surgery impact, histological aspects, and recovery.

Authors:  Fabio Campanella; Franco Fabbro; Tamara Ius; Tim Shallice; Miran Skrap
Journal:  Neuro Oncol       Date:  2015-04-27       Impact factor: 12.300

8.  Pitfalls in the assessment of disability in individuals with low-grade gliomas.

Authors:  Anneli Påhlson; Lena Ek; Gerd Ahlström; Anja Smits
Journal:  J Neurooncol       Date:  2003-11       Impact factor: 4.130

9.  Prediction of neurocognitive outcome in adult brain tumor patients.

Authors:  Thomas A Kaleita; David K Wellisch; Timothy F Cloughesy; Judith M Ford; Donald Freeman; Thomas R Belin; Jeffrey Goldman
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

10.  Effects of surgery on neurocognitive function in patients with glioma: a meta-analysis of immediate post-operative and long-term follow-up neurocognitive outcomes.

Authors:  Justin Choon Hwee Ng; Angela An Qi See; Ting Yao Ang; Lysia Yan Rong Tan; Beng Ti Ang; Nicolas Kon Kam King
Journal:  J Neurooncol       Date:  2018-11-16       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.